Showing results (1-10 of 161) with videos related to
Sort By:
Pageof 17
Clinical and Laboratory Haematology|August 2, 2003
No alteration in platelet function or coagulation induced by EGb761 in a controlled studyC Bal Dit Sollier, H Caplain, L DrouetAnnales De Cardiologie Et D'Angeiologie|November 4, 2017
[Involvement of thrombophilia in coronary thrombosis]C Bal Dit Sollier, L DrouetEuropean Journal of Clinical Investigation|February 11, 2005
Rationale for the use of antifactor Xa in the treatment and prevention of venous and arterial thromboembolic eventsL Drouet, C Bal Dit SollierJournal Des Maladies Vasculaires|September 17, 2002
[Fibrinogen: factor and marker of cardiovascular risk]L Drouet, C Bal Dit SollierAnnales De Cardiologie Et D'Angeiologie|January 18, 2011
[Antiplatelet agents and diabetes mellitus]L Drouet, C Bal dit Sollier, P HenryJournal De Medecine Vasculaire|May 14, 2020
Anticoagulant activity and pleiotropic effects of heparinC Bal Dit Sollier, J-G Dillinger, L DrouetJournal of Cardiovascular Pharmacology|January 1, 1990
Role of serotonin in arteriolar thrombosis and secondary vasospasmL Drouet, C Bal Dit Sollier, S Ruton, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|December 2, 1998
[The role of thrombotic and hemostatic mechanisms in the initial phases of atherosclerosis]L Drouet, E Mazoyer, C Bal dit Sollier, et al.Pathologie-Biologie|April 15, 2008
[Monitoring of anticoagulant treatment in patients with cancer]I Mahé, A Bosquet, A Medjkane, et al.Thrombosis and Haemostasis|February 1, 1995
Antithrombotic effect of a recombinant von Willebrand factor, VCL, on nitrogen laser-induced thrombus formation in guinea pig mesenteric arteriesK Azzam, L I Garfinkel, C Bal dit Sollier, et al.Pageof 17